Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Adv Rheumatol ; 62(1): 35, 2022 10 10.
Article in English | MEDLINE | ID: mdl-36217186

ABSTRACT

Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, some systemic manifestations, mainly liver, gastrointestinal, and pancreatic are not routinely evaluated. To address these manifestations, the Sjögren's Syndrome Committee of the Brazilian Society of Rheumatology conducted a broad systematic review of the literature on studies investigating prevalence and diagnosis of these symptoms in Sjogren´s patients and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. This is the second part of this guideline, providing 6 recommendations for liver, gastrointestinal, and pancreatic care of SS patients.


Subject(s)
Rheumatology , Sjogren's Syndrome , Humans , Brazil/epidemiology , Consensus , Liver , Sjogren's Syndrome/complications , Sjogren's Syndrome/diagnosis , Sjogren's Syndrome/epidemiology
2.
Adv Rheumatol ; 62(1): 18, 2022 06 01.
Article in English | MEDLINE | ID: mdl-35650656

ABSTRACT

Sjogren's Syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, these systemic manifestations are not routinely evaluated and there is no homogenous approach to their diagnosis or evaluation. To close this gap, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of these manifestations and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. The first part of this guideline summarizes the most important topics, and 11 recommendations are provided for the articular, pulmonary, and renal care of SS patients.


Subject(s)
Practice Guidelines as Topic , Rheumatology , Sjogren's Syndrome , Brazil/epidemiology , Consensus , Humans , Meta-Analysis as Topic , Sjogren's Syndrome/complications , Sjogren's Syndrome/diagnosis , Sjogren's Syndrome/epidemiology , Systematic Reviews as Topic
4.
Adv Rheumatol ; 61(1): 54, 2021 09 03.
Article in English | MEDLINE | ID: mdl-34479630

ABSTRACT

Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs. Women with SS often experience gynecological symptoms due to the disease and need extra care regarding their sexual activity, reproductive health and during pregnancy, conditions that are not properly conducted in the clinical practice. To cover this gap, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of symptoms, diagnosis, monitoring, prognosis, and treatment of these manifestations. A Focus Group meeting was held and included experts in the field and methodologists, based on a previously developed script, with themes related to the objective of the study. The most important topics were summarized and 11 recommendations were provided.


Subject(s)
Pregnancy Complications , Sjogren's Syndrome , Brazil , Female , Gynecology , Humans , Obstetrics , Pregnancy , Pregnancy Complications/therapy , Rheumatology , Sjogren's Syndrome/therapy , Societies, Medical
5.
Adv Rheumatol ; 59(1): 58, 2019 12 18.
Article in English | MEDLINE | ID: mdl-31852541

ABSTRACT

BACKGROUND: Primary Sjögren's syndrome (pSS) is a systemic immune-mediated disease whose main characteristic is exocrine gland inflammation and, subsequent reduction in tear and saliva production. A delayed diagnosis is common due to the nonspecific clinical manifestations of disease. The aim of the present study was to develop recommendations for the diagnosis of glandular manifestations of pSS based on evidence and expert opinion. We conducted a systematic literature review to retrieve the best evidence available on the accuracy of diagnostic tests for pSS. We also held two in-person meetings with experts (rheumatologists, pathologists, ophthalmologists and dentists) to establish their level of agreement using the Delphi method. Ultimately, we generated 18 recommendations that aim to facilitate the diagnosis of the glandular manifestations of pSS. CONCLUSION: The diagnosis of glandular manifestations of pSS is complex and multidisciplinary. It requires specific knowledge in the field of ophthalmology, immunology, pathology and imaging, making it compulsory for the rheumatologist to work with professionals from these different areas in order to improve accuracy and early diagnosis. Glandular dysfunction tests, ANA, RF, Anti-Ro, protein electrophoresis, urinalysis, blood count, C-Reactive protein, complement, testing for syphilis and viruses (HCV, HIV) and SGUS should be investigated when dryness or systemic manifestation are present. Minor salivary gland biopsy is recommended for all anti-Ro negative or incomplete criteria cases.


Subject(s)
Sjogren's Syndrome/diagnosis , Brazil , Consensus , Delphi Technique , Dentists , Dry Eye Syndromes/diagnosis , Dry Eye Syndromes/etiology , Humans , Magnetic Resonance Imaging , Ophthalmologists , Pathologists , Positron-Emission Tomography , Rheumatologists , Rheumatology , Salivary Gland Diseases/diagnosis , Salivary Glands/diagnostic imaging , Salivation , Sjogren's Syndrome/complications , Societies, Medical , Ultrasonography , Xerostomia/diagnosis , Xerostomia/etiology
6.
Rev Bras Reumatol ; 55(6): 531-5, 2015.
Article in English, Portuguese | MEDLINE | ID: mdl-26318692

ABSTRACT

The greater understanding of pathophysiology and behavior of systemic vasculitis, together with the development of therapeutic regimens with increasingly better safety and efficacy profiles, dramatically changed the prognosis of patients diagnosed with these clinical entities. Recently, the use of rituximab in the treatment of patients with ANCA-associated vasculitis in randomized clinical trials showed an important alternative in selected cases, especially patients refractory or intolerant to standard therapy with cyclophosphamide and corticosteroids. This article presents the report of seven cases of systemic vasculitis successfully treated with rituximab.


Subject(s)
Antirheumatic Agents/therapeutic use , Rituximab/therapeutic use , Vasculitis/drug therapy , Adrenal Cortex Hormones/therapeutic use , Adult , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy , Antibodies, Monoclonal, Murine-Derived/adverse effects , Cyclophosphamide/therapeutic use , Female , Humans , Male , Middle Aged , Randomized Controlled Trials as Topic , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...